Frequent down-regulation of ABC transporter genes in prostate cancer

BMC Cancer

Volumn 15, Issue 1, 2015, Pages

  Demidenko, Rita ^a   Razanauskas, Deividas ^a   Daniunaite, Kristina ^a   Lazutka, Juozas Rimantas ^a   Jankevicius, Feliksas ^a   Jarmalaite, Sonata ^a  

^a VILNIUS UNIVERSITY   (Lithuania)

Author keywords

ABC transporters; ABCB1; Prostate cancer

Indexed keywords

ABC TRANSPORTER; ABCB1 PROTEIN, HUMAN; MULTIDRUG RESISTANCE PROTEIN;

ABC GENE; ABCA8 GENE; ABCB1 GENE; ABCC10 GENE; ABCC4 GENE; ABCC6 GENE; ABCC9 GENE; ABCD2 GENE; ABCG1 GENE; ABCG4 GENE; ADULT; ARTICLE; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PATHOGENESIS; PROMOTER REGION; PROSTATE CANCER; UPREGULATION; CANCER GRADING; CANCER STAGING; CLUSTER ANALYSIS; CPG ISLAND; GENE EXPRESSION REGULATION; GENETICS; MULTIGENE FAMILY; PATHOLOGY; PROSTATE TUMOR; TRANSCRIPTION INITIATION SITE;

ATP-BINDING CASSETTE TRANSPORTERS; CLUSTER ANALYSIS; CPG ISLANDS; DNA METHYLATION; DOWN-REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MULTIGENE FAMILY; NEOPLASM GRADING; NEOPLASM STAGING; P-GLYCOPROTEINS; PROSTATIC NEOPLASMS; TRANSCRIPTION INITIATION SITE;

EID: 84944059776     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/s12885-015-1689-8     Document Type: Article

References (30)

1. Vasiliou V, Vasiliou K, Nebert DW. Human ATP-binding cassette (ABC) transporter family. Hum Genomics. 2009;3:281-90.
2. Allikmets R, Gerrard B, Hutchinson A, Dean M. HUGO Gene Nomenclature Committee database HGNC. Hum Mol Genet. 1996;5:1649-55. database accessed 25 September 2014.
3. Fletcher JI, Haber M, Henderson MJ, Norris MD. ABC transporters in cancer: more than just drug efflux pumps. Nat Rev Cancer. 2010;10:147-56.
4. Cho E, Montgomery RB, Mostaghel EA. Minireview: SLCO and ABC Transporters: A Role for Steroid Transport in Prostate Cancer Progression. Endocrinology. 2014;155:4124-32.
5. Bhangal G, Halford S, Wang J, Roylance R, Shah R, Waxman J. Expression of the multidrug resistance gene in human prostate cancer. Urol Oncol. 2000;5:118-21.
6. Kawai K, Sakurai M, Sakai T, Misaki M, Kusano I, Shiraishi T, et al. Demonstration of MDR1 P-glycoprotein isoform expression in benign and malignant human prostate cells by isoform-specific monoclonal antibodies. Cancer Lett. 2000;150:147-53.
7. Mishra DK, Chen Z, Wu Y, Sarkissyan M, Koeffler HP, Vadgama JV. Global methylation pattern of genes in androgen-sensitive and androgen-independent prostate cancer cells. Mol Cancer Ther. 2010;9:33-45.
8. Enokida H, Shiina H, Igawa M, Ogishima T, Kawakami T, Bassett WW, et al. CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer. Cancer Res. 2004;64:5956-62.
9. Henrique R, Oliveira AI, Costa VL, Baptista T, Martins AT, Morais A, et al. Epigenetic regulation of MDR1 gene through post-translational histone modifications in prostate cancer. BMC Genomics. 2013;14:898.
10. Fedoruk MN, Giménez-Bonafé P, Guns ES, Mayer LD, Nelson CC. P-glycoprotein increases the efflux of the androgen dihydrotestosterone and reduces androgen responsive gene activity in prostate tumor cells. Prostate. 2004;59:77-90.
11. Lee BH, Taylor MG, Robinet P, Smith JD, Schweitzer J, Sehayek E, et al. Dysregulation of cholesterol homeostasis in human prostate cancer through loss of ABCA1. Cancer Res. 2013;73:1211-8.
12. Imai Y, Asada S, Tsukahara S, Ishikawa E, Tsuruo T, Sugimoto Y. Breast cancer resistance protein exports sulfated estrogens but not free estrogens. Mol Pharmacol. 2003;64:610-8.
13. Zelcer N, Reid G, Wielinga P, Kuil A, van der Heijden I, Schuetz JD, et al. Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4). Biochem J. 2003;371:361-7.
14. Huss WJ, Gray DR, Greenberg NM, Mohler JL, Smith GJ. Breast cancer resistance protein-mediated efflux of androgen in putative benign and malignant prostate stem cells. Cancer Res. 2005;65:6640-50.
15. Ho LL, Kench JG, Handelsman DJ, Scheffer GL, Stricker PD, Grygiel JG, et al. Androgen regulation of multidrug resistance-associated protein 4 (MRP4/ABCC4) in prostate cancer. Prostate. 2008;68:1421-9.
16. Montani M, Hermanns T, Müntener M, Wild P, Sulser T, Kristiansen G. Multidrug resistance protein 4 (MRP4) expression in prostate cancer is associated with androgen signaling and decreases with tumor progression. Virchows Arch. 2013;462:437-43.
17. Sabaliauskaite R, Jarmalaite S, Petroska D, Dasevicius D, Laurinavicius A, Jankevicius F, et al. Combined analysis of TMPRSS2-ERG and TERT for improved prognosis of biochemical recurrence in prostate cancer. Genes Chromosomes Cancer. 2012;51:781-91.
18. Gao P, Yang X, Xue YW, Zhang XF, Wang Y, Liu WJ, et al. Promoter methylation of glutathione S-transferase pi1 and multidrug resistance gene 1 in bronchiole alveolar carcinoma and its correlation with DNA methyltransferase 1 expression. Cancer. 2009;115:3222-32.
19. Kuo HC, Lin PY, Chung TC, Chao CM, Lai LC, Tsai MH, et al. DBCAT: database of CpG islands and analytical tools for identifying comprehensive methylation profiles in cancer cells. J Comput Biol. 2011;18:1013-7. database accessed April 2015.
20. Pachkov M, Erb I, Molina N, van Nimwegen E. Swiss Regulon: a database of genome-wide annotations of regulatory sites. Nucleic Acids Res. 2007;35:D127-31. database accessed April 2015.
21. Cavin Périer R, Junier T, Bucher P. The Eukaryotic Promoter Database EPD. Nucleic Acids Res. 1998;26:353-7. database accessed April 2015.
22. Ellinger J, Bastian PJ, Jurgan T, Biermann K, Kahl P, Heukamp LC, et al. CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancer. Urology. 2008;71:161-7.
23. Guzel E, Karatas OF, Duz MB, Solak M, Ittmann M, Ozen M. Differential expression of stem cell markers and ABCG2 in recurrent prostate cancer. Prostate. 2014;74:1498-505.
24. Liu T, Xu F, Du X, Lai D, Liu T, Zhao Y, et al. Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1. Mol Cell Biochem. 2010;340:265-73.
25. Hu Y, Wang M, Veverka K, Garcia FU, Stearns ME. The ABCA5 protein: a urine diagnostic marker for prostatic intraepithelial neoplasia. Clin Cancer Res. 2007;13:929-38.
26. Yegnasubramanian S, Kowalski J, Gonzalgo ML, Zahurak M, Piantadosi S, Walsh PC, et al. Hypermethylation of CpG islands in primary and metastatic human prostate cancer. Cancer Res. 2004;64:1975-86.
27. Enokida H, Shiina H, Urakami S, Igawa M, Ogishima T, Li LC, et al. Multigene methylation analysis for detection and staging of prostate cancer. Clin Cancer Res. 2005;11:6582-8.
28. Yu J, Zhu T, Wang Z, Zhang H, Qian Z, Xu H, et al. A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer. Clin Cancer Res. 2007;13:7296-304.
29. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science. 2005;310:644-8.
30. Sun C, Dobi A, Mohamed A, Li H, Thangapazham RL, Furusato B, et al. TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation. Oncogene. 2008;27:5348-53.